Role of High Dose Imatinib in BCR/ABLpos/Phpos CML

QR Code (код быстрого отклика)

Role of High Dose Imatinib in BCR/ABLpos/Phpos CML

None

Сохранить в:

Библиографические подробности
Главные авторы:	Petzer, Andreas L., Rumpold, Holger
Формат:	Электронный ресурс Глава книги
Язык:	английский
Опубликовано:	IntechOpen 2012
Предметы:	Health Sciences
Online-ссылка:	https://www.intechopen.com/chapters/25654
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!

Схожие документы

De Novo Acquisition of BCR-ABL Mutations for CML Acquired Resistance
по: Chen, WenYong, и др.
Опубликовано: (2011)

BCR/ABL1 Extra Fusions in Patients with Chronic Myeloid Leukaemia (CML)
по: Vargas, Maria Teresa
Опубликовано: (2011)

3D-QSAR Design of New Bcr-Abl Inhibitors Based on Purine Scaffold and Cytotoxicity Studies on CML Cell Lines Sensitive and Resistant to Imatinib
по: David Cabezas, и др.
Опубликовано: (2025-06-01)

The Role of STAT5 in Tyrosine Kinase Inhibitor (IMATINIB) Resistance in CML Patients
по: Anastasia Putri, и др.
Опубликовано: (2020-02-01)

The Role of STAT5 in Tyrosine Kinase Inhibitor (IMATINIB) Resistance in CML Patients
по: Anastasia Putri, и др.
Опубликовано: (2020-02-01)

ANALYSIS OF RESPONSE TO FIRST-LINE THERAPY WITH IMATINIB IN AZERBAIJANI CML PATIENTS
по: Aypara Hasanova, и др.
Опубликовано: (2025-07-01)

Computational Insights into the Polypharmacological Landscape of BCR-ABL Inhibitors: Emphasis on Imatinib and Nilotinib
по: Rima Hajjo, и др.
Опубликовано: (2025-06-01)

BCR-ABL gene amplification in patients with chronic myeloid leukemia and imatinib resistance
по: S. I. Kutzev, и др.
Опубликовано: (2022-11-01)

Towards the Cure of CML by the Molecular Approach Strategy
по: Cea, Michele, и др.
Опубликовано: (2012)

Molecularly Targeted Therapy: Imatinib and Beyond
по: Poklepovic, Andrew, и др.
Опубликовано: (2012)

BCR-ABL Hits at Mitosis; Implications for Chromosomal Instability, Aneuploidy and Therapeutic Strategy
по: Piwocka, Katarzyna, и др.
Опубликовано: (2011)

Therapeutic Drug Monitoring of Imatinib for Chronic Myeloid Leukemia Patients
по: Takahashi, Naoto, и др.
Опубликовано: (2012)

International CML forum
по: A. G. Turkina
Опубликовано: (2022-11-01)

Isolated thrombocytosis with BCR::ABL1 gene rearrangement – a distinct entity or a variant of chronic myelogenous leukemia (CML)? Case report and review of literature
по: Vipulkumar Prajapati, и др.
Опубликовано: (2025-09-01)

Drug- Induced Pneumonitis: A Rare Complication of Imatinib Mesylate Therapy in Patients with Chronic Myeloid Leukemia
по: Lazareva, O.V., и др.
Опубликовано: (2012)

Nilotinib - new step of success in CML therapy
по: E. G. Lomaia, и др.
Опубликовано: (2022-11-01)

Computational and mechanistic studies on the effect of galactoxyloglucan: Imatinib nanoconjugate in imatinib resistant K562 cells
по: Alphy Rose James, и др.
Опубликовано: (2017-02-01)

High Dose Rate Endobronchial Brachytherapy in Lung Cancer in Patients with Central Airway Obstruction
по: Santini, Alejandro B., и др.
Опубликовано: (2012)

Cumulative Radiation Effective Dose
по: Hayat, Nelofur, и др.
Опубликовано: (2012)

The Role of Low-Dose hCG in the Late Follicular Phase of Controlled Ovarian Hyper Stimulation (COH) Protocols
по: Ashrafi, Mahnaz, и др.
Опубликовано: (2012)

Characterizing the dynamics of BCR repertoire from repeated influenza vaccination
по: Guoqin Mai, и др.
Опубликовано: (2023-12-01)

Imatinib and hypophosphatemia: Case report and review of literature
по: Erdem Şen, и др.
Опубликовано: (2017-07-01)

Case Study in Optimal Dosing in Duodenal Ulcer
по: Peace, Karl E.
Опубликовано: (2011)

Hepatic Lipid Accumulation by High Cholesterol Diet is Inhibited by the Low Dose Fish Oil in Male C57BL/6J Mice
по: Hirako, Satoshi, и др.
Опубликовано: (2012)

Tyrosine kinase inhibitors therapy related neutropenia and thrombocythopenia correction in CML patients
по: V. A. Shuvaev, и др.
Опубликовано: (2014-07-01)

Mutation status of refractory to imatinib patients with chronic myeloid leukemia
по: E. G. Ovsyannikova, и др.
Опубликовано: (2014-07-01)

Optimization of Radiation Dose and Image Quality in Cardiac Catheterization Laboratories
по: Dragusin, Octavian, и др.
Опубликовано: (2011)

REVERSAL OF ACCELERATED PHASE CML WITH HIGH BLAST COUNT FOLLOWING 5+2 CHEMOTHERAPY AND DASATINIB: A CASE REPORT
по: Büşra Akdoğan, и др.
Опубликовано: (2025-07-01)

Treatment efficacy of chronic myeloid leukemia with imatinib in clinical practice
по: A. K. Golenkov, и др.
Опубликовано: (2014-07-01)

Dose Calculations of the Ru/Rh-106 CCA and CCB Eyes Applicators
по: Orion, Itzhak, и др.
Опубликовано: (2012)

Dose Reduction on Computed Tomography Angiography Using Adaptive Control Techniques
по: Cai, Zhijun, и др.
Опубликовано: (2012)

Secondary Analysis of PSA and BCR-Free Survival in Asian Prostate Cancer Patients
по: Gao X, и др.
Опубликовано: (2025-06-01)

THE HISTORY OF CHRONIC MYELOID LEUKEMIA (CML): FROM ARSENIC TO TYROSINE KINASE INHIBITORS (TKI)
по: Rüdiger Hehlmann
Опубликовано: (2025-07-01)

The effect of ubiquitination and deubiquitination to imatinib resistance in gastrointestinal stromal tumors
по: Huade Huo, и др.
Опубликовано: (2025-07-01)

Chronic myeloid leukemia — before and after imatinib (part II)
по: E. G. Lomaia, и др.
Опубликовано: (2022-11-01)

Chronic myeloid leukemia — before and after imatinib (Third part)
по: E. G. Lomaia, и др.
Опубликовано: (2022-11-01)

Chronic myeloid leukemia — before and after imatinib (First part)
по: E. G. Lomaia, и др.
Опубликовано: (2022-11-01)

HIV/AIDS Associated Malignant Disorders: Role of Highly Active Antiretroviral Therapy
по: Mayor, Angel, и др.
Опубликовано: (2012)

Pharmacokinetics and Metabolized Caroteniods in Liver of Single Dose Administration in Fancy Carp (Cyprinus carpio)
по: Yuangsoi, Bundit
Опубликовано: (2012)

Biological Markers of Recurrence and Survival of High-Grade Gliomas: The Role of Hepatocyte Growth Factor
по: García-Navarrete, Roberto, и др.
Опубликовано: (2011)